IGLV2-23
Immunoglobulin lambda variable 2-23
Also known as: LV223_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P01705
- Gene
- IGLV2-23
- Ensembl
- ENSG00000211660
- Chromosome
- 22
- Canonical length
- 113 aa
- Protein class
- Immunoglobulin genes, Predicted secreted proteins
- Secretome location
- Immunoglobulin genes
OverviewNCBI Gene
Predicted to enable antigen binding activity. Predicted to be involved in immune response. Predicted to be located in extracellular region and plasma membrane. Predicted to be part of immunoglobulin complex. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
113 residues, UniProt reviewed canonical sequence.
>P01705|IGLV2-23
1 MAWALLLLTL LTQDTGSWAQ SALTQPASVS GSPGQSITIS CTGTSSDVGS YNLVSWYQQH
61 PGKAPKLMIY EGSKRPSGVS NRFSGSKSGN TASLTISGLQ AEDEADYYCC SYALocalizationUniProt · AlphaFold · HPA
Whether an antibody against IGLV2-23 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 0
- Highest tissue expression
- 1,495 nTPM
Expression across tissuesHPA
Tissue
- tonsil: 1,495 nTPM
- duodenum: 649 nTPM
- stomach: 632 nTPM
- colon: 593 nTPM
- lymph node: 584 nTPM
- spleen: 502 nTPM
Single-cell type
- plasma cells: 62 nCPM
- parietal cells: 8.8 nCPM
- gastric chief cells: 8.7 nCPM
- megakaryocytes: 6.2 nCPM
- mucous neck cells: 4.4 nCPM
- foveolar cells: 2.9 nCPM
Immune cell
- naive B-cell: 2,618 nTPM
- memory B-cell: 2,082 nTPM
- total PBMC: 232 nTPM
- neutrophil: 6.3 nTPM
- classical monocyte: 3.1 nTPM
- myeloid DC: 2.6 nTPM
Brain region
- cerebral cortex: 1.9 nTPM
- medulla oblongata: 1.8 nTPM
- amygdala: 1.2 nTPM
- choroid plexus: 1.1 nTPM
- pons: 0.7 nTPM
- basal ganglia: 0.4 nTPM
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads IGLV2-23 as an antibody target. Whether an autoantibody or antibody against IGLV2-23 could matter depends on whether native IGLV2-23 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
IGLV2-23 is annotated at the cell surface, where native IGLV2-23 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label IGLV2-23 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...